We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.77B
AUM Growth
-$20M
Cap. Flow
-$279M
Cap. Flow %
-15.76%
Top 10 Hldgs %
16.25%
Holding
547
New
90
Increased
94
Reduced
221
Closed
118

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$32.2M
2
A icon
Agilent Technologies
A
+$10.1M
3
INCY icon
Incyte
INCY
+$9.9M
4
APC
Anadarko Petroleum
APC
+$9.65M
5
NOW icon
ServiceNow
NOW
+$9.61M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$22.6M
2
AGN
Allergan plc
AGN
+$19.6M
3
CPRI icon
Capri Holdings
CPRI
+$18.6M
4
DAL icon
Delta Air Lines
DAL
+$17.6M
5
NTNX icon
Nutanix
NTNX
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 24.23%
3 Consumer Discretionary 14.95%
4 Industrials 7.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIT
526
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-1,349,233
Closed -$6.71M
MINI
527
DELISTED
Mobile Mini Inc
MINI
– –
-23,259
Closed -$738K
UNT
528
DELISTED
UNIT Corporation
UNT
– –
-30,416
Closed -$434K
AGN
529
DELISTED
Allergan plc
AGN
– –
-146,944
Closed -$19.6M
OMN
530
DELISTED
OMNOVA Solutions Inc.
OMN
– –
-21,606
Closed -$158K
INAP
531
DELISTED
Internap Corporation
INAP
– –
-70,700
Closed -$293K
IPHS
532
DELISTED
Innophos Holdings, Inc.
IPHS
– –
-18,200
Closed -$446K
ACHN
533
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-69,391
Closed -$110K
PCMI
534
DELISTED
PCM, Inc
PCMI
– –
-11,315
Closed -$199K
WP
535
DELISTED
Worldpay, Inc.
WP
– –
-54,327
Closed -$4.15M
BRS
536
DELISTED
Bristow Group, Inc.
BRS
– –
-126,000
Closed -$306K
ULTI
537
DELISTED
Ultimate Software Group Inc
ULTI
– –
-34,514
Closed -$8.45M
NTRI
538
DELISTED
NutriSystem, Inc.
NTRI
– –
-91,500
Closed -$4.01M
MB
539
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
– –
-76,500
Closed -$2.79M
P
540
DELISTED
Pandora Media Inc
P
– –
-1,007,131
Closed -$8.15M
IMPV
541
DELISTED
Imperva, Inc.
IMPV
– –
-16,429
Closed -$915K
WIN
542
DELISTED
Windstream Holdings Inc
WIN
– –
-100,500
Closed -$210K
WLL
543
DELISTED
Whiting Petroleum Corporation
WLL
– –
-6,205
Closed -$10.6M
CY
544
DELISTED
Cypress Semiconductor
CY
– –
-1,198,631
Closed -$15.2M
CELG
545
DELISTED
Celgene Corp
CELG
– –
-235,815
Closed -$15.1M
STMP
546
DELISTED
Stamps.com, Inc.
STMP
– –
-46,328
Closed -$7.21M
BHVN
547
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-46,057
Closed -$1.7M
18 19 20 21
22

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q1 2019 Portfolio in Review

As of Q1 2019, PDT Partners held 547 positions worth $1.77B, down 1.1% from $1.79B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

PDT Partners withdrew a net $279M in Q1 2019, closing 118 positions and reducing 221 holdings. Its most notable exit was Morgan Stanley, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Bristol-Myers Squibb worth $30.8M.

  • PDT Partners's largest Q1 2019 buy was Bristol-Myers Squibb: 645,994 shares worth $30.8M.
  • PDT Partners added most to Anadarko Petroleum in Q1 2019, an estimated $9.65M increase.
  • PDT Partners's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $11.6M.
  • PDT Partners fully exited Morgan Stanley in Q1 2019, selling an estimated $22.6M.
  • PDT Partners's ten largest holdings make up 16% of its $1.77B portfolio in Q1 2019.
  • PDT Partners opened 90 new positions and closed 118 in Q1 2019.
  • PDT Partners's portfolio value fell 1.1% quarter-over-quarter to $1.77B.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.